Sameem Abedin@sameem_abedin

Leukemia/BMT Doc, dad, steeler fan(atic)

 Milwaukee, WI
Joined November 2018
10 Photos and videos
Sameem Abedin retweeted
Froedtert
@Froedtert
10 May 2023
We are proud of staff like Darryl Taylor, who works at Froedtert Hospital in Environmental Services. Darryl went the extra mile in his workday, offering support and friendship to patient Lindsey Jacob and her family. tmj4.com/news/local-news/can…

Cancer Connection: Hospital housekeeper who lost wife, builds special bond with cancer patient and...

Despite what he has gone through in his own life, Darryl has been a blessing to others through their darkest times.

tmj4.com
1
1
8
945
Sameem Abedin retweeted
Cam Harless
@camharless
1 Mar 2023
every american president, but they're all cool and they all sport a mullet 46. Joe Biden
2,275
15,642
104,668
19,628,500
This good boy is 9 years old today
12
574
We at @MedicalCollege are looking for energetic faculty looking to build a career in HCT & CART therapy with a focus on myeloid &/or plasma cell disorder. Home of @CIBMTR / @BMTCTN + - No🌪️ - No - No 🔥 - No 🌀 Chilly yes but warm Friendly people. DM or meet at Tandem #bmtsm
2
12
44
7,438
A morning of clay sculpting/painting to answer the ultimate what if… what if instead of an iceberg, a bloop actually ate the Titanic?
3
213
Sameem Abedin retweeted
FIFA World Cup
@FIFAWorldCup
18 Dec 2022
MESSI SCORES FOR ARGENTINA!!
1,079
16,067
121,463
6,249,297
Whoa
1
134
In leukemias, are there any studies demonstrating benefit to post-HCT maintenance therapy in patients who enter transplant in an MRD negative state? Thanks @MediHumdani @sghmd @DrChrisHourigan
1
203
#ASH22. After single induction (7+3), for residual disease, lower intensity re-induction (Ven/HMA) was feasible and comparable to another cycle of 7+3, leading to less time in the hospital, NF and transfusions. MCW experience, but now a widespread practice.
1
3
17
Have a pt with Int Risk AML, got 7+3 and D+15&20 marrow 13% blasts. Discussed MA HCT, put him on a low intensity trtmt (HMA/Ven), said we’ll do HCT ASAP. This was 3 wks ago, have a Peer to Peer on Friday to seek HLA typing relatives…
1
#ASH22 thanks for the soccer coverage this weekend, but where can I watch FOOTBALL today?
Pittsburgh Steelers
@steelers
11 Dec 2022
1️⃣4️⃣
1
Sameem Abedin retweeted
AML Hub
@AML_Hub
10 Dec 2022
CONGRESS | #ASH22 Sameem Abedin @sameem_abedin, @MedicalCollege shows 53% 1 year OS and 32% at 2 years with salvage lintuzumab-Ac225 (actimab-A) plus CLAG-M in phase 1 trial in patients with R/R AML, with 64% progressing to allo-HSCT. #leusm #medicalcongress
6
7
Wow, Go Blue!
1
1
Responses: 52% achieved a CRc. At our RP2D, 67% achieved CRc. CRc patients mostly (72%) were MRD negative by MFC. Most patients had at least 1 year of follow up, and we observed a median OS of 1 year, and estimated 2-year survival of 32%. 9/
1
1
In summary - safe to give LintuzumabAc225 at low doses with intensive chemo. Counts come back. Given study population, LintuzumabAc225 appears to add in eliminating disease; would not have expected as high or as long of a response with salvage in this population.
2
Load more